School of Medicine
Showing 541-560 of 2,421 Results
-
Timothy Ellis-Caleo, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Timothy Ellis-Caleo is a board-certified, fellowship-trained medical oncologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Ellis-Caleo specializes in caring for people with thoracic and gastrointestinal cancers. His clinical interests include immunotherapy and precision oncology, with a focus on bringing the latest advances in cancer treatment to patients. He works closely with each patient to develop personalized treatment plans that reflect their goals, values, and individual needs while incorporating evidence-based therapies and access to innovative clinical trials when appropriate.
As a physician-researcher, Dr. Ellis-Caleo focuses on improving treatments for patients with solid tumors through translational research and clinical investigation. His research has explored the tumor microenvironment and its role in predicting response to immunotherapy, molecular biomarkers for lung cancer, and the use of artificial intelligence to improve cancer care and surveillance.
Dr. Ellis-Caleo has authored numerous peer-reviewed publications in leading medical journals, including Nature Cancer, Nature Communications, NPJ Digital Medicine, and Journal of Clinical Oncology (JCO) Precision Oncology. He has presented his research at national and international meetings, including the American Society of Clinical Oncology Annual Meeting and the World Conference on Lung Cancer.
Dr. Ellis-Caleo is a member of Alpha Omega Alpha Honor Medical Society and Sigma Xi, The Scientific Research Honor Society. -
Jennie Lisabeth Ellison
Casual Employee, Medicine
Current Role at StanfordGrant & Communications Writer
-
Hany Elmariah
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Hany Elmariah is an Associate Professor in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Elmariah earned his MD and his MS in Biomedical Engineering at the University of Florida. He completed an Internal Medicine Residency at Duke University. Dr. Elmariah then completed a Hematology and Oncology Fellowship at Johns Hopkins University, where he also served as Chief Fellow. He then was a faculty member at the Moffitt Cancer Center before joining the faculty at Stanford University. Dr. Elmariah's clinical focus is allogeneic transplant for myeloid malignancies including acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. His research is focused on haploidentical and mismatched unrelated donor blood and marrow transplantation and novel cellular therapies for myeloid malignancies.
-
Michelle Yixiao Engle, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Michelle Engle grew up in Virginia, though she has also lived in China and Canada. She moved to California for medical training and quickly grew attached to the Bay Area. She is board-certified in family medicine and palliative medicine, providing holistic care to patients of all ages.
Her hobbies include barre, board games, escape rooms, cooking, and rock climbing. -
Edgar Engleman
Professor of Pathology and of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
-
David Epstein
Clinical Assistant Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interestspulmonary infections, bronchiectasis, and suppurative lung diseases complicating BMT and CAR-T; bronchiectasis; NTM infections
-
Ali Etemadi
Postdoctoral Scholar, Nephrology
Current Research and Scholarly InterestsI am a clinician and data scientist focusing on drawing causal inferences from observational data when randomized controlled trials are not feasible. Currently, my work centers on patients with late-stage chronic kidney disease, a rapidly growing population for which evidence is limited due to their frequent exclusion from RCTs. At the moment, I aim to move towards precision medicine approaches to optimize outcomes for these patients.
-
Markus Eyting
Postdoctoral Fellow, Medicine - Primary Care and Population Health
BioI am an applied microeconomist, using experimental methods as well as survey and administrative data to study the interplay of beliefs and individual decision-making with applications to health, discrimination, and machine learning.
For more information, please visit my website: https://meyting.com/.
